Literature DB >> 24072826

A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.

Naoko Takeuchi1, Toru Arai, Masanori Kitaichi, Yoshikazu Inoue.   

Abstract

A 49-year-old man with superficial lymphadenopathy presented with symptoms of low-grade fever, general fatigue and weight loss. On examination, multiple superficial lymphadenopathies and brown macules were observed on the trunk. Laboratory studies revealed an elevation of serum C reactive protein and interleukin 6 (IL-6) in addition to polyclonal hyperimmunoglobulinaemia. High-resolution CT of the chest showed bilateral multiple nodules and patchy ground-glass opacities with interstitial thickening. Biopsy of the cervical lymph node and skin biopsy showed numerous perivascular plasma cells, which were characteristic of the plasma cell type of Castleman's disease. Surgical lung biopsy showed hyalinising granuloma, which are hyalinous nodular lesions surrounded by lymphoid cells. He was diagnosed with multicentric Castleman's disease complicated by pulmonary hyalinising granulomas; his symptoms improved by treatment with tocilizumab, which is a humanised antihuman IL-6 receptor monoclonal antibody and corticosteroid. This is the first report of a comorbid case successfully treated with tocilizumab and corticosteroid.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24072826      PMCID: PMC3794123          DOI: 10.1136/bcr-2013-010233

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

2.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

3.  Pulmonary hyalinizing granuloma.

Authors:  P Engleman; A A Liebow; J Gmelich; P J Friedman
Journal:  Am Rev Respir Dis       Date:  1977-06

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

5.  Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.

Authors:  N Nishimoto; M Sasai; Y Shima; M Nakagawa; T Matsumoto; T Shirai; T Kishimoto; K Yoshizaki
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

6.  Pulmonary hyalinizing granuloma.

Authors:  S A Yousem; L Hochholzer
Journal:  Am J Clin Pathol       Date:  1987-01       Impact factor: 2.493

7.  Pulmonary hyalinizing granuloma with Castleman's disease.

Authors:  S Atagi; M Sakatani; M Akira; S Yamamoto; E Ueda
Journal:  Intern Med       Date:  1994-11       Impact factor: 1.271

8.  Multicentric giant lymph node hyperplasia.

Authors:  A R Gaba; R S Stein; D L Sweet; D Variakojis
Journal:  Am J Clin Pathol       Date:  1978-01       Impact factor: 2.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.